Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

NCT00318474 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

184

Enrollment

OTHER

Sponsor class

Stopped DSMB recommended stopping the trial because of lack of effect.

Conditions

IgA Nephropathy

Interventions

DRUG: Mycophenolate Mofetil (MMF)
DRUG: MMF Placebo
DRUG: ACEi
DRUG: FOS

Sponsor

St. Joseph's Hospital and Medical Center, Phoenix